Navigation Links
Personalized Treatments for Cancer Are Revolutionizing Patient Care
Date:6/15/2010

PORTLAND, Ore., June 15 /PRNewswire-USNewswire/ -- Raju Kucherlapati, Professor of Genetics at Harvard University—where he pioneered the use of genomic data in clinical decision making—will be addressing the Controlled Release Society on the subject of recent revolutionary advancements in personalized treatments for cancer patients.

"If you were diagnosed with non small cell lung cancer before 2003, there were not many treatment choices available to you," says Professor Kucherlapati. "If you are diagnosed with the same type of cancer today, it is most likely that the pathologist would order a series of genetic tests on the biopsy or surgically resected sample." The results of these tests would then be used to develop individually tailored approaches to patient treatment.

According to Professor Kucherlapati, the genetic tests performed on the tumor tissue would include the mutational status of EGFR, K-RAS, B-RAF, EML-ALK4 translocation, ErbB2 amplification, and perhaps others. Depending on the test results, a variety of treatments tailored to the specific type of tumor identified may be recommended by the oncologist.

For example, if the tumor being tested has certain types of EGFR mutations and does not have a K-RAS mutation, the oncologist may decide to treat the patient with a class of drugs called tyrosine kinase inhibitors.  If the tumor has ErbB2 amplification, the patient may be recommended to enroll in a clinical trial to evaluate the efficacy of Herceptin—a drug approved for treatment of certain breast cancer patients.  If the tumor has an EML-ALK4 translocation, the patient may be recommended to enter a different clinical trial for a drug being developed by Pfizer to treat patients with this particular
'/>"/>

SOURCE Controlled Release Society
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Arrowhead Releases New Report Assessing State of Personalized Medicine Market
2. HistoRx Receives Key Patent on Application of AQUA(R) Technology to Personalized Medicine
3. Reportlinker Adds The Future of Nutrigenomics: New opportunities in personalized nutrition and food-pharma collaboration
4. QuantaLife, Inc. Unanimously Selected as the Most Promising Company at the Personalized Medicine World Conference 2010
5. Champions Biotechnology to Present Data at AACR-EORTC 2009 Regarding the Predictability of Biomerk Tumorgraft(TM) Platform to Guide Personalized Cancer Treatment and Accelerate Oncology Drug Development
6. Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference
7. Genedata Expressionist with New Transcriptomics Biomarker Capabilities Advances Drug Development for Personalized Medicine
8. Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration Agreement
9. Axial Biotech Enters Partnership with the University of Utah to Utilize the Utah Population Database to Develop Personalized Diagnostic Tests for Spine Disorders
10. Champions Biotechnology, Inc. Establishes UK Subsidiary and Retains General Manager to Expand Its Personalized Oncology Business
11. Automated Sequence Capture for Next-Generation Sequencing Paves the Way for Personalized Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... CA (PRWEB) February 26, 2015 The ... online demonstration to support life extension technologies and awareness. ... UTC, Universal Coordinated Time, on March 21st 2015, in ... world. , Eric Schulke, Founder of MILE, says, ... act with urgency. The Movement for Indefinite Life Extension ...
(Date:2/26/2015)... Pittsburgh, PA (PRWEB) February 26, 2015 ... March 9 -12, at the Ernest N. Morial ... 919 exhibitors (count as of February 19, 2015) ... community in industrial, academic, and government labs. The ... such as, but not limited to, analytical chemistry; ...
(Date:2/26/2015)... JUPITER, Fla. , Feb. 26, 2015 /PRNewswire/ ... biotechnology company whose patented and proprietary technologies are ... other proteins for the bioenergy, bio-based chemical, biopharmaceutical ... will report its financial results for year ending ... March 11, 2015 and will host a conference ...
(Date:2/26/2015)... 26, 2015   Lexicon Pharmaceuticals, Inc. (Nasdaq: ... at the Cowen 35 th Annual Health Care Conference ... Boston .  Lexicon management will provide an ... A webcast of the presentation will be available through Lexicon,s ... presentation will be available at www.lexpharma.com until April ...
Breaking Biology Technology:Indefinite Life Extension Activists Organize Online Demonstration 2Indefinite Life Extension Activists Organize Online Demonstration 3Pittcon 2015 Announces Exposition Highlights 2Dyadic International To Announce Fourth Quarter 2014 Financial Results And Host Conference Call On Wednesday, March 11, 2015 2Dyadic International To Announce Fourth Quarter 2014 Financial Results And Host Conference Call On Wednesday, March 11, 2015 3Lexicon To Present At The Cowen 35th Annual Health Care Conference 2
... Boston Scientific Corporation (NYSE: BSX ) ... and news announcements at the 30th Annual Scientific Sessions ... 13 to 16 in Boston. Highlights of the ... II clinical trial and the ALTITUDE Clinical Science Program. ...
... packaging equipment manufacturer, Sepha Ltd, enters strategic European alliances and gears ... Achema 2009 , ... Belfast (Vocus) May 11, 2009 ... and de-blistering equipment, Sepha Ltd is boosting its ...
... Pa., May 8 BioTrends Research Group released highlights from ... a four wave syndicated research study that will track uptake ... launch. The research is based on results of a ... May 7th. 95% of the Rheumatologists surveyed were aware ...
Cached Biology Technology:Boston Scientific Announces Company Schedule for Heart Rhythm Society Scientific Sessions 2Boston Scientific Announces Company Schedule for Heart Rhythm Society Scientific Sessions 3Boston Scientific Announces Company Schedule for Heart Rhythm Society Scientific Sessions 4Boston Scientific Announces Company Schedule for Heart Rhythm Society Scientific Sessions 5Pharmaceutical Packaging Equipment Manufacturer Boosts European Distribution 2Pharmaceutical Packaging Equipment Manufacturer Boosts European Distribution 3Baseline Research Indicates High Interest in Centocor-Ortho Biotech's SIMPONI(R) 2
(Date:2/10/2015)... WALTHAM, Mass., Feb. 10, 2015  Alere Inc. ... announced its financial results for the quarter ended ... Executive Officer and President of Alere said, "We ... refocussing Alere as the global leader in rapid ... closing the Alere Health divestiture in early January ...
(Date:2/5/2015)... 5, 2015  Marken is starting its 35 th ... launched a new marketing campaign to solidify its place ... new campaign focuses on First as a ... The first headline in the series, ... with its client,s priorities. Marken recognizes the need to ...
(Date:2/5/2015)... Calif. , Jan. 27, 2015 /PRNewswire/ ... provider of globally deployed, innovative test solutions ... announced the delivery of its TS-323 ... Space Systems Company (LMSSC). GENASYS is a ... demands of mission-critical applications that require performance ...
Breaking Biology News(10 mins):Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33Alere Inc. Announces Fourth Quarter 2014 Results 34Alere Inc. Announces Fourth Quarter 2014 Results 35Alere Inc. Announces Fourth Quarter 2014 Results 36
... for cancer therapy has been identified by Monash University ... a gene involved in cancer development. , A team ... of Immunology, has identified two proteins that are involved ... telomerase that is essential if cancer cells are to ...
... accumulation of genetic damage in our cells is a major ... published today in the journal Nature by an international group ... critical gene for repairing damaged DNA grow old rapidly and ... that grow old naturally. Furthermore, the premature aging symptoms of ...
... (NRL) and Purdue University have shed light on one ... magnetic. Their description of how being magnetic "helps" ... of the Biophysical Journal. , Magnetic bacteria are found ... and lakes. The strain of bacterium the research ...
Cached Biology News:New target for cancer therapy identified 2Buildup of damaged DNA in cells drives aging 2Buildup of damaged DNA in cells drives aging 3Buildup of damaged DNA in cells drives aging 4Researchers reveal mystery of bacterial magnetism 2